Insulin and glucagon levels of umbilical cord blood in appropriate for gestational age - preterm infants with or without postnatal hypoglycemia
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: To determine whether serum insulin and glucagon levels of umbilical cord blood correlate with subsequent postnatal hypoglycemia in appropriate for gestational age (AGA) – preterm infants at different gestational ages (GAs). Methods: The serum insulin and glucagon levels of umbilical cord blood were measured using magnetic bead based multiplex immunoassay in 69 AGA - premature infants, stratified according to GA: GA 23–30 weeks, early preterm (EP, n=31); GA 31–34 weeks, late preterm (LP, n=38). Postnatal hypoglycemia was defined as a capillary glucose level <40 mg/dL within the first 60 minutes of life, regardless of GA. Results: The capillary glucose concentration in EP infants (65.5±21.2 mg/dL) was significantly higher than that of LP infants (55.9±17.3 mg/dL) (P=0.043). The serum glucagon level in EP infants (44.3±28.7 pg/mL) was significantly higher than that in LP infants (28.1±13.6 pg/mL) (P=0.006). There was not a significant difference in serum insulin level between EP and LP infants (372.7±254.2 pg/mL vs. 372.4±209.1 pg/mL, P=0.996). There was a significant difference in the serum glucagon level between infants with and without hypoglycemia (27.7±8.9 mg/dL vs. 36.8± 24.6 mg/dL, P=0.036), but not in the serum insulin level (451.9±256.9 pg/mL vs. 357.4±222.2 pg/mL, P=0.211). Postnatal glucose concentration within the first 60 minutes of life had a significant positive correlation with serum glucagon levels (r=0.256, P=0.034), but not with serum insulin levels (r=–0.020, P=0.867). Conclusion: Lower glucagon levels of cord blood were seen in premature infants with higher GA, which might contribute to the occurrence of postnatal hypoglycemia.
Abstract
Purpose: To determine whether serum insulin and glucagon levels of umbilical cord blood correlate with subsequent postnatal hypoglycemia in appropriate for gestational age (AGA) – preterm infants at different gestational ages (GAs). Methods: The serum insulin and glucagon levels of umbilical cord blood were measured using magnetic bead based multiplex immunoassay in 69 AGA - premature infants, stratified according to GA: GA 23–30 weeks, early preterm (EP, n=31); GA 31–34 weeks, late preterm (LP, n=38). Postnatal hypoglycemia was defined as a capillary glucose level <40 mg/dL within the first 60 minutes of life, regardless of GA. Results: The capillary glucose concentration in EP infants (65.5±21.2 mg/dL) was significantly higher than that of LP infants (55.9±17.3 mg/dL) (P=0.043). The serum glucagon level in EP infants (44.3±28.7 pg/mL) was significantly higher than that in LP infants (28.1±13.6 pg/mL) (P=0.006). There was not a significant difference in serum insulin level between EP and LP infants (372.7±254.2 pg/mL vs. 372.4±209.1 pg/mL, P=0.996). There was a significant difference in the serum glucagon level between infants with and without hypoglycemia (27.7±8.9 mg/dL vs. 36.8± 24.6 mg/dL, P=0.036), but not in the serum insulin level (451.9±256.9 pg/mL vs. 357.4±222.2 pg/mL, P=0.211). Postnatal glucose concentration within the first 60 minutes of life had a significant positive correlation with serum glucagon levels (r=0.256, P=0.034), but not with serum insulin levels (r=–0.020, P=0.867). Conclusion: Lower glucagon levels of cord blood were seen in premature infants with higher GA, which might contribute to the occurrence of postnatal hypoglycemia.
참고문헌 (32)
- Kalhan SC, "Glucose production in pregnant women at term gestation. Sources of glucose for human fetus", J Clin Invest, 63, pp.388~394 (1979)
- Bloom SR, "Failure of glucagon release in infants of diabetic mothers", Br Med J, 4, pp.453~454 (1972)
- Heck LJ, "Serum glucose levels in term neonates during the first 48 hours of life", J Pediatr, 110, pp.119~122 (1987)
- Srinivasan G, "Plasma glucose values in normal neonates: a new look", J Pediatr, 109, pp.114~117 (1986)
- Sperling MA, "Spontaneous and amino acid-stimulated glucagon secretion in the immediate postnatal period. Relation to glucose and insulin", J Clin Invest, 53, pp.1159~1166 (1974)
- Cornblath M, "Blood glucose in the neonate and its clinical significance", N Engl J Med, 273, pp.378~381 (1965)
- Cowett RM, "Persistent glucose production during glucose infusion in the neonate", J Clin Invest, 71, pp.467~475 (1983)
- Kalhan SC, "Role of glucose in the regulation of endogenous glucose production in the human newborn", Pediatr Res, 20, pp.49~52 (1986)
- Zhou W, "Hypoglycemia incidence and risk factors assessment in hospitalized neonates", J Matern Fetal Neonatal Med, 28, pp.422~425 (2015)
- Jain A, "Hypoglycemia in the newborn", Indian J Pediatr, 77, pp.1137~1142 (2010)
- Hume R, "Failure to detect preterm infants at risk of hypoglycemia before discharge", J Pediatr, 134, pp.499~502 (1999)
- Jackson L, "Plasma catecholamines and the counterregulatory responses to hypoglycemia in infants: a critical role for epinephrine and cortisol", J Clin Endocrinol Metab, 89, pp.6251~6256 (2004)
- Hawdon JM, "Patterns of metabolic adaptation for preterm and term infants in the first neonatal week", Arch Dis Child, 67(4 Spec No), pp.357~365 (1992)
- Mitanchez D, "Glucose regulation in preterm newborn infants", Horm Res, 68, pp.265~271 (2007)
- Lyall H, "Early detection of metabolic abnormalities in preterm infants impaired by disorders of blood glucose concentrations", Clin Chem, 40, pp.526~530 (1994)
- Lucas A, "Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia", BMJ, 297, pp.1304~1308 (1988)
- Duvanel CB, "Long-term effects of neonatal hypoglycemia on brain growth and psychomotor development in small-forgestational-age preterm infants", J Pediatr, 134, pp.492~498 (1999)
- Bagnoli F, "Glucagon and insulin cord blood levels in very preterm, late preterm and full-term infants", J Pediatr Endocrinol Metab, 27, pp.419~423 (2014)
- 임정섭, "New Korean reference for birth weight by gestational age and sex: data from the Korean Statistical Information Service (2008–2012)", Annals of Pediatirc Endocrinology & Metabolism, 19(3), pp.146~153 (2014), 대한소아내분비학회
- Kattwinkel J, "Part 15: neonatal resuscitation: 2010American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care", Circulation, 122(18 Suppl 3), pp.S909~S919 (2010)
- Collins JE, "Hyperinsulinism in asphyxiated and small-for-dates infants with hypoglycaemia", Lancet, 2, pp.311~313 (1984)
- Carmen S, "Neonatal hypoglycemia in response to maternal glucose infusion before delivery", J Obstet Gynecol Neonatal Nurs, 15, pp.319~323 (1986)
- Christesen HB, "Prolonged elimination of tolbutamide in a premature newborn with hyperinsulinaemic hypoglycaemia", Eur J Endocrinol, 138, pp.698~701 (1998)
- Lubchenco LO, "Incidence of hypoglycemia in newborn infants classified by birth weight and gestational age", Pediatrics, 47, pp.831~838 (1971)
- Ju Young Yoon, "Blood glucose levels within 7 days after birth in preterm infants according to gestational age", Annals of Pediatirc Endocrinology & Metabolism, 20(4), pp.213~219 (2015), 대한소아내분비학회
- Vuguin PM, "Ablation of the glucagon receptor gene increases fetal lethality and produces alterations in islet development and maturation", Endocrinology, 147, pp.3995~4006 (2006)
- Pipeleers DG, "Interplay of nutrients and hormones in the regulation of glucagon release", Endocrinology, 117, pp.817~823 (1985)
- Riesenfeld T, "Respiratory water loss in relation to gestational age in infants on their first day after birth", Acta Paediatr, 84, pp.1056~1059 (1995)
- Roberts D, "Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth", Cochrane Database Syst Rev, (3), pp.CD004454~ (2006)
- Koivisto M, "Blood glucose level in preterm infants after antenatal exposure to glucocorticoid", Acta Paediatr, 96, pp.664~668 (2007)
- Pettit KE, "The association of antenatal corticosteroids with neonatal hypoglycemia and hyperbilirubinemia", J Matern Fetal Neonatal Med, 27, pp.683~686 (2014)
- Padbury JF, "Catecholamine and endorphin responses to delivery in term and preterm lambs", Dev Pharmacol Ther, 11, pp.44~50 (1988)
